• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流：最后的前沿领域。

Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation: The Last Frontier.

作者信息

Tagliari Ana Paula, Petersen Saadi Rodrigo, Keller Saadi Eduardo

机构信息

Post Graduate Program in Cardiology and Cardiovascular Science, Federal University of Rio Grande do Sul, Porto Alegre 90035-002, Brazil.

Cardiovascular Surgery Department, Hospital São Lucas da PUC-RS, Porto Alegre 90619-900, Brazil.

出版信息

J Clin Med. 2022 Sep 1;11(17):5181. doi: 10.3390/jcm11175181.

DOI:10.3390/jcm11175181
PMID:36079111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9457283/
Abstract

Transcatheter aortic valve implantation (TAVI) to treat patients with severe symptomatic aortic stenosis is a well-established procedure. Even though cases series have reported TAVI use in high-risk patients with pure native aortic regurgitation, this is still considered an off-label intervention, especially when the aortic annulus dimensions are beyond the recommended by prosthesis manufacturers. Herein, we provide an updated review regarding the transcatheter treatment of pure native aortic regurgitation and illustrate this issue by presenting a clinical case of a patient with pure aortic regurgitation and a large aortic annulus who received a self-expanding non-dedicated transcatheter heart valve.

摘要

经导管主动脉瓣植入术（TAVI）用于治疗有严重症状的主动脉瓣狭窄患者是一种成熟的手术。尽管病例系列报道了TAVI在高危单纯原发性主动脉瓣反流患者中的应用，但这仍被视为一种超适应证干预，尤其是当主动脉瓣环尺寸超出假体制造商推荐范围时。在此，我们提供了关于单纯原发性主动脉瓣反流经导管治疗的最新综述，并通过展示一例单纯主动脉瓣反流且主动脉瓣环较大的患者接受自膨胀非专用经导管心脏瓣膜治疗的临床病例来说明这一问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/085f873893c5/jcm-11-05181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/3e96a50044d7/jcm-11-05181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/4f8de28728e4/jcm-11-05181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/ab589674b118/jcm-11-05181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/472f4b34e9b1/jcm-11-05181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/396f36e9c43e/jcm-11-05181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/f9075a4119e8/jcm-11-05181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/085f873893c5/jcm-11-05181-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/3e96a50044d7/jcm-11-05181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/4f8de28728e4/jcm-11-05181-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/ab589674b118/jcm-11-05181-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/472f4b34e9b1/jcm-11-05181-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/396f36e9c43e/jcm-11-05181-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/f9075a4119e8/jcm-11-05181-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b381/9457283/085f873893c5/jcm-11-05181-g007.jpg

相似文献

1
Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation: The Last Frontier.经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流：最后的前沿领域。
J Clin Med. 2022 Sep 1;11(17):5181. doi: 10.3390/jcm11175181.
2
Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation.经导管主动脉瓣置换术治疗原发性主动脉瓣反流
Interv Cardiol. 2015 Mar;10(1):49-54. doi: 10.15420/icr.2015.10.1.49.
3
Case Report: Transcatheter aortic valve implantation using balloon-expandable bioprosthesis in patients with severe pure aortic regurgitation on noncalcified native valves: a series of cases.病例报告：在非钙化天然瓣膜的重度单纯主动脉瓣反流患者中使用球囊扩张式生物假体进行经导管主动脉瓣植入术：一系列病例
Front Cardiovasc Med. 2024 Apr 26;11:1365181. doi: 10.3389/fcvm.2024.1365181. eCollection 2024.
4
TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve.使用自膨胀式经导管心脏瓣膜治疗单纯非钙化性主动脉瓣反流的经导管主动脉瓣置入术
Front Cardiovasc Med. 2022 Jan 25;8:743579. doi: 10.3389/fcvm.2021.743579. eCollection 2021.
5
Transcatheter aortic valve implantation in patients with a small aortic annulus: performance of supra-, intra- and infra-annular transcatheter heart valves.经导管主动脉瓣植入术在小主动脉瓣环患者中的应用：跨瓣环上、瓣环内和瓣环下经导管心脏瓣膜的性能。
Clin Res Cardiol. 2021 Dec;110(12):1957-1966. doi: 10.1007/s00392-021-01918-8. Epub 2021 Aug 13.
6
Successful transcatheter aortic valve implantation for pure aortic regurgitation using a new second generation self-expanding J-Valve(TM) system - the first in-man implantation.使用新型第二代自膨胀J-Valve(TM)系统成功进行经导管主动脉瓣植入治疗单纯主动脉瓣反流——首例人体植入。
Heart Lung Circ. 2015 Apr;24(4):411-4. doi: 10.1016/j.hlc.2014.10.007. Epub 2014 Oct 30.
7
TAVI for Pure Native Aortic Regurgitation: Are We There Yet?经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流：我们做到了吗？
Interv Cardiol. 2019 Feb;14(1):26-30. doi: 10.15420/icr.2018.37.1.
8
Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation.
J Heart Valve Dis. 2016 Jul;25(4):498-500.
9
[Transcatheter aortic valve implantation for pure aortic regurgitation].经导管主动脉瓣植入术治疗单纯主动脉瓣反流
G Ital Cardiol (Rome). 2021 Sep;22(9 Suppl 1):21S-28S. doi: 10.1714/3675.36613.
10
Overinflation of balloon-expandable valves for transcatheter treatment of pure noncalcified native aortic regurgitation: How much oversizing is needed and achievable?用于经导管治疗单纯非钙化性原发性主动脉瓣反流的球囊扩张瓣膜过度膨胀：需要多大的尺寸以及能够达到多大尺寸？
Catheter Cardiovasc Interv. 2023 Feb;101(2):481-484. doi: 10.1002/ccd.30529. Epub 2022 Dec 21.

引用本文的文献

1
Severe aortic regurgitation: the limits of TAVI.重度主动脉瓣反流：经导管主动脉瓣植入术的局限性
EuroIntervention. 2024 Sep 2;20(17):e1051-e1052. doi: 10.4244/EIJ-E-24-00045.
2
Predictors of permanent pacemaker implantation in aortic valve diseases after TAVI with vitaFlow liberty system.使用vitaFlow liberty系统进行经导管主动脉瓣置换术后主动脉瓣疾病患者永久性起搏器植入的预测因素
Front Cardiovasc Med. 2023 Sep 29;10:1277528. doi: 10.3389/fcvm.2023.1277528. eCollection 2023.
3
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation.

本文引用的文献

1
Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- early-generation devices.使用新一代早期器械经导管主动脉瓣置换术治疗单纯原发性主动脉瓣反流的结果。
Ann Transl Med. 2022 Jan;10(1):24. doi: 10.21037/atm-21-6936.
2
TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve.使用自膨胀式经导管心脏瓣膜治疗单纯非钙化性主动脉瓣反流的经导管主动脉瓣置入术
Front Cardiovasc Med. 2022 Jan 25;8:743579. doi: 10.3389/fcvm.2021.743579. eCollection 2021.
3
2021 ESC/EACTS Guidelines for the management of valvular heart disease.
经皮球囊扩张式主动脉瓣置换术治疗非钙化性主动脉瓣反流的临床疗效。
EuroIntervention. 2023 Sep 18;19(7):580-588. doi: 10.4244/EIJ-D-23-00344.
4
Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation: one-year outcomes of a single-center study.经股动脉入路主动脉瓣置换术治疗单纯性主动脉瓣反流：单中心研究的 1 年结果。
BMC Cardiovasc Disord. 2023 Jun 29;23(1):330. doi: 10.1186/s12872-023-03329-1.
2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
4
Transcatheter Aortic Valve Implantation in Severe Native Pure Aortic Regurgitation Following Endocarditis With Large Vegetation.感染性心内膜炎伴巨大赘生物致严重原发性单纯主动脉瓣反流的经导管主动脉瓣植入术
JACC Case Rep. 2021 Jun 16;3(6):859-863. doi: 10.1016/j.jaccas.2021.03.020. eCollection 2021 Jun.
5
Sapien 3 Embolization From Ventricle to Aorta in the Setting of Noncalcified Aortic Regurgitation.在非钙化性主动脉瓣反流情况下，Sapien 3从心室到主动脉的栓塞
JACC Case Rep. 2021 Jan 13;3(1):64-68. doi: 10.1016/j.jaccas.2020.11.024. eCollection 2021 Jan.
6
[Transcatheter aortic valve implantation for aortic regurgitation in patients with left ventricular assist device].[经导管主动脉瓣植入术用于左心室辅助装置患者的主动脉瓣反流]
G Ital Cardiol (Rome). 2021 Mar;22(3 Suppl 1):39S-42S. doi: 10.1714/3578.35633.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南：执行摘要：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17.
8
Structural Valve Deterioration after Transcatheter Aortic Valve Implantation Using J-Valve: A Long-Term Follow-Up.使用J-Valve经导管主动脉瓣植入术后的结构性瓣膜退变：长期随访
Ann Thorac Cardiovasc Surg. 2020 Jun 20;26(3):158-165. doi: 10.5761/atcs.oa.19-00325. Epub 2020 Apr 3.
9
Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry).经导管主动脉瓣植入术治疗原发性主动脉瓣反流的自膨式瓣膜系统（来自 STS/ACC TVT 注册研究）。
Am J Cardiol. 2019 Sep 1;124(5):781-788. doi: 10.1016/j.amjcard.2019.05.045. Epub 2019 Jun 6.
10
Meta-Analysis and Meta-Regression of Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation.经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流的荟萃分析和荟萃回归。
Heart Lung Circ. 2020 May;29(5):729-741. doi: 10.1016/j.hlc.2019.04.012. Epub 2019 May 4.